ORPHAN MEDICAL INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: ORPHAN MEDICAL INC, 10-Q, 2000-08-14
Next: EAST TEXAS FINANCIAL SERVICES INC, NT 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
ACCOMPANYING BALANCE SHEETS OF ORPHAN MEDICAL, INC. AS OF JUNE 30, 1999 AND THE
RELATED STATEMENTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       1,882,260
<SECURITIES>                                13,358,506
<RECEIVABLES>                                1,582,900
<ALLOWANCES>                                   163,800
<INVENTORY>                                    752,054
<CURRENT-ASSETS>                            17,520,566
<PP&E>                                         844,330
<DEPRECIATION>                                 429,870
<TOTAL-ASSETS>                              17,964,265
<CURRENT-LIABILITIES>                        3,279,799
<BONDS>                                              0
                                0
                                        115
<COMMON>                                        84,213
<OTHER-SE>                                  14,600,138
<TOTAL-LIABILITY-AND-EQUITY>                17,964,265
<SALES>                                      5,767,583
<TOTAL-REVENUES>                             5,767,583
<CGS>                                          893,046
<TOTAL-COSTS>                                  893,046
<OTHER-EXPENSES>                             7,135,917
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (357,019)
<INCOME-PRETAX>                             (1,904,361)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (1,904,361)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (2,329,943)
<EPS-BASIC>                                      (0.30)
<EPS-DILUTED>                                    (0.30)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission